Last edition
News about "Orchid Pharma "
Orchid Pharma and Cipla to Launch Cefepime-Enmetazobactam in India
Orchid Pharma has launched its new drug, Cefepime-Enmetazobactam, which has been approved for the treatment of complicated Urinary Tract infections (cUTI), Hospital-Acquired Pneumonia (HAP) and Ventilator-Associated Pneumonia (VAP) indications.
Orchid Pharma | 29/06/2024 | By Aishwarya | 152
Orchid Pharma Gets DCGI Approval for Enmetazobactam
Orchid Pharma has secured Drugs Controller General of India (DCGI) approval for the manufacturing and marketing of its invented New Chemical Entity Active Pharmaceutical Ingredient (API), Enmetazobactam.
Orchid Pharma | 10/06/2024 | By Aishwarya | 114
Orchid Pharma to Enter Consumer Business
The company manufactures formulations and APIs across segments.
Orchid Pharma | 30/08/2023 | By Manvi | 560
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy